An experimental new approach to fighting melanoma is providing some strikingly encouraging results. And now researchers are hopeful they might be able to use the same approach against other cancers. The new approach uses something called immunotherapy medications that are designed to trigger the body’s immune system, allowing it to fight the cancer on its own. Several clinical studies are testing the drugs and the results are already a key focus at this year's American Society of Clinical Oncology meeting in Chicago. Read more here.
Study mentioned: Wolchok JD, et al. Nivolumab plus Ipilimumab in Advanced Melanoma. N Engl J Med. Online June 2, 2013.
No comments:
Post a Comment